surmount-1 trial tirzepatide weight loss nondiabetic Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 Tirzepatide Was Associated with Improved
Description
Supporting information References 1
Vitamin B12 monitoring is not routinely indicated for patients on GLP-1/GIP therapy alone but may be considered for those also taking metformin or with risk factors for deficiency
Choose the one thats easiest for you, and rotate spots weekly to avoid irritation
The research base draws on Phase 2/3 trials, mechanistic studies, and metabolic outcomes research across multiple institutions
